FindTrial
Sign In

Clinical study on the effectiveness and safety of modified bicaval techniques in orthotopic heart transplantation on the treatment of end-stage heart failure

Clinical study on the effectiveness and safety of modified bicaval techniques in orthotopic heart transplantation on the treatment of end-stage heart failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054593
Enrollment
Unknown
Registered
2021-12-20
Start date
2015-06-01
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage heart failure

Interventions

Standard bicaval anastomosis technique group:None
Modified bicaval anastomosis technique group:None

Sponsors

People's Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with end-stage heart failure requiring heart transplantation; 2. Have detailed clinical data, complete personal information and follow-up data; 3. Aged 16 to 72 years.

Exclusion criteria

Exclusion criteria: 1. Patients requiring combined organ transplantation and re-heart transplantation; 2. Those who are participating in other clinical trials or are considered unsuitable for clinical trials by researchers for other reasons.

Design outcomes

Primary

MeasureTime frame
clinical information;—

Countries

China

Contacts

Public ContactWang Zhiwei

People's Hospital of Wuhan University

wangzhiwei@whu.edu.cn+86 13995628899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026